{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:51:53Z","timestamp":1785523913897,"version":"3.56.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Approximately 39.9 million people are living with HIV worldwide, most in sub-Saharan Africa. Effective antiretroviral therapy has shifted attention to metabolic comorbidities, and emerging evidence links integrase inhibitors such as dolutegravir to elevated serum uric acid, yet the global burden of hyperuricemia and gout in this population is unquantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This protocol describes a systematic review and meta-analysis of observational studies (cross-sectional, cohort, and case-control) published from inception to May 2026. We will search PubMed\/MEDLINE, EMBASE, Web of Science, and CINAHL. Studies involving adults (\u226518 years) living with HIV that report the prevalence or incidence of hyperuricemia or gout will be included. Two independent reviewers will screen studies, extract data, and assess risk of bias using the Joanna Briggs Institute Prevalence Critical Appraisal Checklist and the Newcastle-Ottawa Scale (NOS). Primary outcomes are the pooled prevalence of hyperuricemia and gout in PLHIV. Secondary outcomes include risk factors associated with urate dysregulation (ART regimen, Cluster of Differentiation 4 [CD4] count, viral load, metabolic comorbidities, and HIV duration), and gout as an immune reconstitution inflammatory syndrome (IRIS) manifestation. A random-effects meta-analysis using the DerSimonian-Laird method with Freeman-Tukey double-arcsine transformation for prevalence data will be performed in R software. Heterogeneity will be assessed using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic and Cochran\u2019s Q test. Subgroup analyses will explore variation by ART class (pre-ART, PI, NNRTI, INSTI\/dolutegravir era), geographic region, CD4 category, and study quality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>PROSPERO Registration Number<\/jats:title>\n                    <jats:p>CRD420261360734.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0355217","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:29:16Z","timestamp":1785518956000},"page":"e0355217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urate dysregulation (hyperuricemia and gout) among people living with HIV: A protocol for a systematic review and meta-analysis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0768-1315","authenticated-orcid":true,"given":"Ivaan","family":"Pitua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Andrew","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiragga Denis","family":"Lwembawo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaweesi Calvin","family":"Nantalaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Nampiinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9866-2238","authenticated-orcid":true,"given":"Michael","family":"Ndyomugabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6365-5018","authenticated-orcid":true,"given":"James Nelson","family":"Okema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"pone.0355217.ref001","doi-asserted-by":"crossref","first-page":"1665666","DOI":"10.3389\/fpubh.2025.1665666","article-title":"The global response to HIV\/AIDS in sub-Saharan Africa: achievements, challenges, and perspectives for the future","volume":"13","author":"S Orlando","year":"2025","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0355217.ref002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12981-025-00745-5","article-title":"Global, regional and national burden of HIV\/AIDS among individuals aged 15-79 from 1990 to 2021","volume":"22","author":"Y Chen","year":"2025","journal-title":"AIDS Res Ther"},{"issue":"1","key":"pone.0355217.ref003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12992-025-01181-w","article-title":"The successful scaling-up of antiretroviral therapy globally has many lessons for advancing universal health coverage: progress at risk","volume":"22","author":"Y Assefa","year":"2025","journal-title":"Glob Health"},{"key":"pone.0355217.ref004","article-title":"Scale-up of HIV treatment through PEPFAR: a historic public health achievement","author":"WM El-Sadr","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0355217.ref005","doi-asserted-by":"crossref","first-page":"1370725","DOI":"10.3389\/fmed.2024.1370725","article-title":"Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study","volume":"11","author":"NC Waritu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"pone.0355217.ref006","doi-asserted-by":"crossref","DOI":"10.1177\/23259582251400988","article-title":"Magnitude of hyperuricemia and its associated factors among people living with human immunodeficiency virus who enrolled in first-line antiretroviral therapy in Amhara Region, Ethiopia","volume":"24","author":"M Jemal","year":"2025","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"pone.0355217.ref007","article-title":"Prevalence and factors associated with hyperuricemia among people living with HIV in Uganda: a cross-sectional study at a tertiary hospital in Uganda","volume":"12","author":"J Mutinye Kwesiga","year":"2025","journal-title":"Ther Adv Infect Dis"},{"issue":"4","key":"pone.0355217.ref008","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s43657-024-00212-7","article-title":"Insights into causal associations of lipid traits and lipid-modifying drug targets with uric acid and risk of Gout","volume":"5","author":"C Zou","year":"2025","journal-title":"Phenomics"},{"issue":"10","key":"pone.0355217.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0333368","article-title":"Global burden of gout among young people from 1990 to 2021, with projections for 2050: A systematic analysis based on the Global Burden of Disease Study 2021","volume":"20","author":"P Tian","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"pone.0355217.ref010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4078\/jrd.2024.0054","article-title":"The pathogenesis of gout","volume":"32","author":"EY Ahn","year":"2025","journal-title":"J Rheum Dis"},{"issue":"3","key":"pone.0355217.ref011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0956462418799803","article-title":"Prevalence of and risk factors for gout in HIV-positive adults: a case-control study","volume":"30","author":"P Nicholson","year":"2019","journal-title":"Int J STD AIDS"},{"issue":"5","key":"pone.0355217.ref012","first-page":"362","article-title":"Is ritonavir boosting associated with gout?","volume":"16","author":"S Creighton","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"1","key":"pone.0355217.ref013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/RHU.0b013e3181c78ddc","article-title":"Refractory polyarticular gouty arthritis as a manifestation of immune reconstitution inflammatory syndrome","volume":"16","author":"PJ Sebeny","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"pone.0355217.ref014","first-page":"231","article-title":"Gota aguda como manifesta\u00e7\u00e3o da s\u00edndrome inflamat\u00f3ria de reconstitui\u00e7\u00e3o imune ap\u00f3s in\u00edcio de terapia antirretroviral","volume":"54","author":"WDA Eyer-Silva","year":"2012","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"pone.0355217.ref015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0253-7184.120542","article-title":"Musculoskeletal and rheumatological disorders in HIV infection: experience in a tertiary referral center","volume":"34","author":"AK Kole","year":"2013","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"1","key":"pone.0355217.ref016","first-page":"24","article-title":"Rheumatic manifestations among HIV positive adults attending the Infectious Disease Clinic at Mulago Hospital","volume":"11","author":"M Kaddu-Mukasa","year":"2011","journal-title":"Afr Health Sci"},{"issue":"6","key":"pone.0355217.ref017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/2141-9248.177985","article-title":"Clinical and laboratory predictors of articular disorders among HIV-infected patients seen at teaching hospital Southeast Nigeria","volume":"5","author":"CC Okwara","year":"2015","journal-title":"Ann Med Health Sci Res"},{"key":"pone.0355217.ref018","first-page":"234","article-title":"Hyperuricemia, its prevalence and correlation with metabolic syndrome in anti-retroviral naive HIV cohort: review of the literature","volume":"2","author":"NJ Patel","year":"2013","journal-title":"J Immunol Tech Infect Dis"},{"issue":"1","key":"pone.0355217.ref019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31138\/mjr.33.1.75","article-title":"Septic arthritis complicating a gout flare: report of two cases and review of the literature","volume":"33","author":"P Tzanis","year":"2022","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"pone.0355217.ref020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12691\/ajmcr-13-4-1","article-title":"A diagnostic challenge: gout mimics septic arthritis in a CKD patient","volume":"13","author":"N Al-Sudani","year":"2025","journal-title":"Am J Med Case Rep"},{"key":"pone.0355217.ref021","article-title":"PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to address in a systematic review protocol","volume":"350","author":"L Shamseer","year":"2015","journal-title":"Br Med J"},{"key":"pone.0355217.ref022","doi-asserted-by":"crossref","first-page":"1356859","DOI":"10.3389\/fendo.2024.1356859","article-title":"The positive association between hyperuricemia and polycystic ovary syndrome and analysis of related factors","volume":"15","author":"Z Gong","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0355217.ref023","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"L Du","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"pone.0355217.ref024","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pone.0355217.ref025","first-page":"7","author":"JB Institute","year":"2016"},{"key":"pone.0355217.ref026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"CK-L Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"pone.0355217.ref027","volume-title":"Measuring inconsistency in meta-analyses Testing for heterogeneity","author":"JPT Higgins"},{"key":"pone.0355217.ref028","volume-title":"Papers Bias in meta-analysis detected by a simple, graphical test","author":"M Egger"},{"issue":"2","key":"pone.0355217.ref029","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"S Duval","year":"2000","journal-title":"Biometrics"},{"issue":"7650","key":"pone.0355217.ref030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"key":"pone.0355217.ref031","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2025"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:29:20Z","timestamp":1785518960000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0355217"}},"subtitle":[],"editor":[{"given":"Junzheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0355217","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}